2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC2494 | |||||||||||||||||||||||
Submitter : | Mrs. Zora DeGrandpre | Date & Time: | 02/15/2006 04:02:36 | |||||||||||||||||||||
Organization : | Mrs. Zora DeGrandpre | |||||||||||||||||||||||
Category : | Health Professional | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Bio-identical hormones clearly have fewer side effects over hormone analogs. The data are in and have been for some time. Wyeth labs is just as clearly attempting to use the FDA to promote their own business and their own fiduciary interests. Bio-identical hormones must remain an option, both for consumers and for health providers. Anything less would be scientifically invalid, ethically reprehensible and morally insupportable. | ||||||||||||||||||||||||